Louis Picker, M.D., and his team have been awarded a $25 million grant from the Bill & Melinda Gates Foundation that will spur their work on a vaccine candidate against HIV. This work is based on previous findings that this candidate, which uses cytomegalovirus as a vector, can boost effector memory T cells to successfully target simian immunodeficiency virus. This new award will test the safety of a prototype human version of the vaccine in a phase I clinical trial in humans, as well as optimize the vaccine for phase II trials. Read the OHSU media release here, and here’s the Oregonian story.
About the author
Other posts by this author:
- Medical Research Foundation Awards Celebrate Leading Oregon Scientists
- OHSU receives four new instrumentation grants to bolster research capacity
- Kimbree Brown, Ph.D., to join OHSU as director of postdoctoral affairs
- What you need to do and don’t need to do for your NIH Biosketch by May 25, 2021–and beyond
- Update on Uniform Guidance Procurement Policies for Sponsored Projects